FROM Emmanuel Reinert
Poppies, Jihadis Stand in the Way of Progress in Afghanistan At Camp David on Monday, with Afghanistan's President Hamid Karzai by his side, President Bush warmly endorsed a "jirga ," a traditional meeting to resolve disputes. Pakistan's President, Pervez Musharraf , had agreed to attend tomorrow's meeting in Kabul, but today declined, saying the press of business will keep him at home in Islamabad. Musharraf says he hopes lower-ranking officials can resolve issues between the two countries, but his withdrawal is seen as a snub to the United States. Bush and Karzai say al Qaeda in Pakistan is helping the Taliban stage a bloody resurgence, which is also fueled by a record crop of opium poppies. Will Karzai have to go it alone? Would legalizing poppy-production help ease the pressure. Can the "jirga" make a difference, without either Musharraf or the Taliban?
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
The longest US war: Will Trump send more troops to Afghanistan? The Trump White House is divided over the Pentagon's request for more troops in Afghanistan—where the US has been fighting for the past 16 years. Is there a formula -- either for "victory" or a political settlement? Is there an end in sight for America's longest war?
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.